Dr. Callanan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
801 W Randol Mill Rd
Suite 101
Arlington, TX 76012Phone+1 817-261-9625
Education & Training
- University of Miami/Jackson Health System/Bascom Palmer Eye InstituteResidency, Ophthalmology, 1990 - 1992
- University of Texas Southwestern Medical CenterResidency, Ophthalmology, 1987 - 1990
- University of Texas Southwestern Medical CenterResidency, Internal Medicine, 1983 - 1985
- University of Iowa Roy J. and Lucille A. Carver College of MedicineClass of 1983
- Luther CollegeB.A., 1975
Certifications & Licensure
- TX State Medical License 1984 - 2026
- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2013
- Senior Honor Award American Society of Retinal Specialists, 2012
- Join now to see all
Clinical Trials
- Ranibizumab and Reduced Fluence PDT for AMD Start of enrollment: 2007 May 01
- Prophylactic Anecortave Acetate in Patients With a Retisert Implant Start of enrollment: 2006 Sep 01
- Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study Start of enrollment: 2010 Feb 01
- Join now to see all
Publications & Presentations
PubMed
- 118 citationsPharmacogenetics for Genes Associated with Age-related Macular Degeneration in the Comparison of AMD Treatments Trials (CATT)Stephanie A. Hagstrom, Gui-Shuang Ying, Gayle J.T. Pauer, Gwen M. Sturgill-Short, Jiayan Huang
Ophthalmology. 2013-03-01 - 173 citationsComparison of the modified Early Treatment Diabetic Retinopathy Study and mild macular grid laser photocoagulation strategies for diabetic macular edema.Donald S. Fong, Samara F. Strauber, Lloyd Paul Aiello, Roy W. Beck, David Callanan
Archives of Ophthalmology. 2007-04-01 - 49 citationsTreating chronic noninfectious posterior segment uveitis: the impact of cumulative damage. Proceedings of an expert panel roundtable discussion.Quan Dong Nguyen, David Callanan, Pravin U. Dugel, David G. Godfrey, Debra A. Goldstein
Retina. 2006-10-01
Journal Articles
- Use of Corticosteroids in the Treatment of Patients With Diabetic Macular Edema Who Have a Suboptimal Response to Anti-VEGF: Recommendations of an Expert PanelRegillo CD, Callanan DG, Fine HF, Do DV, Holekamp NM, Kuppermann BD, Singer MA, Singh RP, Ophthalmic Surg Lasers Imaging Retina, 1/1/2017
- A multicenter, 12-month randomized study comparing dexamethasone intravitreal implant with ranibizumab in patients with diabetic macular edemaCallanan DG, Loewenstein A, Patel SS, Massin P, Corcostegui B, Li XY, Jiao J, Hashad Y, Whitcup SM, Graefes Arch Clin Exp Ophthalmol, 1/1/2017
- Twenty-four-Month Outcomes of the Ranibizumab for Edema of the Macula in Diabetes - Protocol 3 with High Dose (READ-3) StudySepah YJ, Sadiq MA, Boyer D, Callanan D, Gallemore R, Bennett M, Marcus D, Halperin L, Hassan M, Campochiaro PA, Nguyen QD, Do D, Ophthalmology, 1/1/2016
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- "Combination Therapy for Exudative Age Related Macular Degeneration"Callanan DG, XXVIth Meeting of the Club Jules Gonin, St. Moritz, Switzerland, 1/12/2008
- Fluocinolone Acetonide Intravitreal Implant for the Treatment of Uveitis Affecting the Posterior Segment: 34 Week Results of a Randomized, Masked, Multi-center Clinica...Fluocinolone Acetonide Uveitis Study Group, American Uveitis Society, Vail, CO, 1/19/2004
Lectures
- "The OZAB Study: A 6 Month, Prospective, Randomized Study of the Effects of Dexamethasone Intravitreal Implant with Bevacizumab Compared to Bevacizumab Alone for Centr...Jersey, The Channel Islands - 1/13/2018
- "Implantation of Drug Delivery Devices"Guangzhou, China - 1/13/2017
- "Abicipar Pegol (Anti-Vegf Darpin) Phase 2, Doublemasked, Randomized Study In Treatment-Na�ve Patients With Neovascular Age-Related Macular Degeneration"Bordeaux, France - 1/7/2016
- Join now to see all
Other
- Guidelines for Interpreting Retinal Photographs and Coding Findings in the Submacular Surgery trials: SSt report NO. 8.Submacular Surgery Trials Research Group
- Histo-pathological and Ultrastructural Features of Surgically-excised Subfoveal Choroidal Neovascular Lesions: SST Report NO. 7.Submacular Surgery Trials Research Group
Press Mentions
- Aviceda Completes Enrollment for Phase 2b SIGLEC Study for Geographic Atrophy TreatmentSeptember 24th, 2024
- Aviceda Therapeutics Announces Formation of Executive TeamJanuary 11th, 2021
- NEW PRODUCT APPLICATIONS: Yutiq Implant for Chronic Noninfectious Posterior-Segment UveitisApril 1st, 2019
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: